MetLife Investment Management’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-125,461
Closed -$3.72M 2846
2023
Q4
$3.72M Sell
125,461
-2,433
-2% -$72.1K 0.03% 649
2023
Q3
$2.03M Hold
127,894
0.02% 897
2023
Q2
$2.41M Buy
127,894
+17,450
+16% +$329K 0.02% 857
2023
Q1
$424K Hold
110,444
﹤0.01% 1745
2022
Q4
$548K Hold
110,444
﹤0.01% 1585
2022
Q3
$528K Buy
110,444
+9,667
+10% +$46.2K ﹤0.01% 1597
2022
Q2
$453K Sell
100,777
-7,699
-7% -$34.6K ﹤0.01% 1731
2022
Q1
$516K Buy
108,476
+38,679
+55% +$184K ﹤0.01% 1752
2021
Q4
$518K Buy
69,797
+10,556
+18% +$78.3K ﹤0.01% 1488
2021
Q3
$336K Sell
59,241
-14,457
-20% -$82K ﹤0.01% 1762
2021
Q2
$486K Hold
73,698
﹤0.01% 1591
2021
Q1
$597K Buy
73,698
+14,366
+24% +$116K 0.01% 1424
2020
Q4
$383K Buy
59,332
+3,331
+6% +$21.5K ﹤0.01% 1611
2020
Q3
$202K Sell
56,001
-21,499
-28% -$77.4K ﹤0.01% 1862
2020
Q2
$357K Hold
77,500
﹤0.01% 1563
2020
Q1
$264K Buy
77,500
+17,754
+30% +$60.5K ﹤0.01% 1545
2019
Q4
$305K Hold
59,746
﹤0.01% 1737
2019
Q3
$145K Hold
59,746
﹤0.01% 2127
2019
Q2
$130K Hold
59,746
﹤0.01% 2261
2019
Q1
$162K Hold
59,746
﹤0.01% 2089
2018
Q4
$287K Hold
59,746
﹤0.01% 1708
2018
Q3
$566K Hold
59,746
0.01% 1457
2018
Q2
$581K Buy
59,746
+13,727
+30% +$133K 0.01% 1321
2018
Q1
$484K Hold
46,019
0.01% 1387
2017
Q4
$295K Buy
+46,019
New +$295K ﹤0.01% 1720